STOCK TITAN

Nexus Uranium Announces Closing of $1.92 Million Financing

The financing adds capital for uranium projects, while share-based awards and a paid research agreement add dilution and costs.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Nexus Uranium (NEXUF) has closed its previously announced non-brokered prospectus offering of units, raising gross proceeds of $1,922,786.88. Each unit contains one common share and one warrant exercisable at $0.70 until April 16, 2028. Nexus intends to advance its uranium property portfolio in South Dakota and Arizona and fund general corporate needs.

Insiders purchased 228,035 units for $127,699.60. Nexus issued 216,866 finder's warrants on the same exercise terms, with no cash finder's fees. It also granted 600,000 deferred share units to directors, officers and consultants, vesting quarterly over one year. A services agreement with HoldCo Markets Advisory covers equity research and information distribution, including social media, from October 16, 2026 to October 16, 2027 for $44,625 including taxes. It then automatically extends quarterly at $3,700 per month.

Loading...
Loading translation...
3 points · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 5 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Major pointCompleted offering raised $1,922,786.88 in gross proceeds. 30% of market cap
  • Minor point. Forward-looking: it has not happened yet and may not happen.Nexus intends to use proceeds to advance uranium properties in South Dakota and Arizona.
  • Minor pointFinder compensation required no cash fees.

Negative

  • Major pointOffering units dilute holders through one common share and one warrant, exercisable at $0.70 until April 16, 2028.
  • Minor pointIssued 216,866 finder's warrants, an 8.0% fee on certain subscriptions, exercisable at $0.70 until April 16, 2028.
  • Minor pointGranted 600,000 deferred share units, adding share-based compensation vesting 25% every three months over one year.
  • Minor point. Forward-looking: it has not happened yet and may not happen.HoldCo Markets Advisory agreement costs $44,625 including taxes for October 16, 2026 through October 16, 2027.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Services agreement automatically extends quarter-to-quarter after its initial term at $3,700 per month.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Vancouver, British Columbia--(Newsfile Corp. - October 19, 2026) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: NEXUF) (FSE: JA7) ("Nexus" or the "Company") is pleased to announce that it has closed its previously announced non-brokered prospectus offering of units (the "Units") for gross proceeds of $1,922,786.88 (the "Offering"). Each Unit is comprised of one common share of the Company (a "Common Share") and one Common Share purchase warrant of the Company (a "Warrant"). Each Warrant entitles the holder to acquire one Common Share at an exercise price of $0.70 per Common Share until April 16, 2028.

In connection with the Offering, the Company issued an aggregate of 216,866 finder's warrants (the "Finder's Warrants") to eligible finders, representing a 8.0% finder's fee on certain subscriptions in the Offering. Each Finder's Warrant entitles the holder to acquire one Common Share at an exercise price of $0.70 per Common Share until April 16, 2028. The Company did not pay any cash finder's fees in connection with the Offering.

The Company intends to use the proceeds from the Offering to advance the Company's uranium property portfolio in South Dakota and Arizona, and for general working capital and corporate purposes.

The Offering was made by means of the Company's amended and restated prospectus supplement dated October 13, 2026, amending and restating the prospectus supplement dated September 10, 2026 (the "Amended Prospectus Supplement"), and the accompanying base shelf prospectus dated February 3, 2026 (the "Shelf Prospectus"). Complete details of the Offering are set out in the Amended Prospectus Supplement. The Amended Prospectus Supplement together with the Shelf Prospectus can be obtained under the Company's SEDAR+ profile at www.sedarplus.ca.

The securities referenced in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any applicable state securities laws and may not be offered or sold in the United States or to "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act) absent such registration or an applicable exemption from such registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy such securities in any jurisdiction.

Pursuant to Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") the Company advises that certain insiders purchased an aggregate of 228,035 Units for $127,699.60 as part of the Offering. These insiders are considered to be related parties of the Company and subscription by a "related party" of the Company is considered to be a "related party transaction" for the purposes of MI 61-101. The Company is relying on the exemptions from the formal valuation requirement and minority shareholder approval requirements in sections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, as the fair market value of the related parties participation of the Offering is not more than 25% of the Company's market capitalization.

Award Grants

The Company also announces that it has granted an aggregate of 600,000 deferred share units ("DSUs") to certain directors, officers, and consultants of the Company, pursuant to its 2023 omnibus equity incentive compensation plan. All DSUs will vest over a one-year period in four equal tranches, with 25% vesting every three months from the date of grant.

The DSUs and the underlying common shares are subject to a four-month hold period in accordance with applicable Canadian securities laws and the policies of the Canadian Securities Exchange.

Corporate Update

The Company is pleased to announce that it has entered into a professional services agreement (the "Agreement") dated September 22, 2026, with HoldCo Markets Advisory Inc. ("HCM"), an independent investment management firm based in Toronto. Pursuant to the Agreement, HCM will conduct equity research and provide information distribution and social media services for a twelve-month term from October 16, 2026 to October 16, 2027 (the "Term"). The Company has agreed to pay an aggregate of $44,625 (including taxes) to HCM for its services. Following the Term, the Agreement will automatically extend on a quarter-to-quarter basis at a monthly rate of $3,700. No securities-based compensation has been provided or is contemplated to be provided to HCM pursuant to the Agreement. HCM can be reached at Hudson's Bay Centre, 2 Bloor St. E., Toronto, ON, M4W 3T3; Tel: (416) 903-7522; Email: mwichterle@holdcomarkets.com.

About Nexus Uranium Corp.

Nexus is focused on meeting growing domestic uranium demand driven by the nuclear energy renaissance and the AI-powered data center buildout. Nexus Uranium Corp. is a uranium exploration company advancing a portfolio of uranium projects in the United States and Canada. In the United States, the Company holds the resource-stage Chord Project in Fall River County, South Dakota, the Wolf Canyon, Deadhorse, and RC projects in South Dakota, and the South Pass and Great Divide Basin projects in Wyoming (the Great Divide Basin project is currently under option). The Company also holds the Arizona Strip Project, comprising 38 BLM lode mining claims covering seven collapse breccia pipe uranium targets in Mohave County, Arizona, including the JD Property which is currently under option. In Canada, Nexus holds the Mann Lake project in Saskatchewan's Athabasca Basin. The Company's US projects are potentially amenable to in-situ recovery (ISR) mining methods. For more information, visit www.nexusuranium.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Jeremy Poirier
Chief Executive Officer
(604) 722-9842
info@nexusuranium.com

Forward-Looking Statements

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the intended use of proceeds of the Offering, the Company's plans to advance its uranium property portfolio in South Dakota and Arizona, the vesting of the DSUs granted by the Company and the scope and term of HCM's engagement and the services that HCM will provide to the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will", "will be", "intends", or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by management of the Company, they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended including without limitation those factors discussed under the heading "Risk Factors" in the Shelf Prospectus and the Amended Prospectus Supplement and other filings of the Company with the Canadian Securities Authorities, copies of which can be found under the Company's profile on SEDAR+. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319700

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Nexus Uranium raise, and what securities did investors receive?

Nexus Uranium raised $1,922,786.88 in gross proceeds through a completed non-brokered prospectus offering. Each unit includes one common share and one warrant allowing the holder to purchase one common share at $0.70 until April 16, 2028.

What restrictions apply to Nexus Uranium's deferred share unit grants?

The deferred share units and their underlying common shares are subject to a four-month hold period under applicable Canadian securities laws and Canadian Securities Exchange policies. The awards vest in four equal tranches over one year, with 25% vesting every three months from the grant date.

Keep reading